PT1265904E - Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento - Google Patents
Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamentoInfo
- Publication number
- PT1265904E PT1265904E PT01911553T PT01911553T PT1265904E PT 1265904 E PT1265904 E PT 1265904E PT 01911553 T PT01911553 T PT 01911553T PT 01911553 T PT01911553 T PT 01911553T PT 1265904 E PT1265904 E PT 1265904E
- Authority
- PT
- Portugal
- Prior art keywords
- preparation
- treatment
- pharmaceutically acceptable
- acceptable carrier
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10004572A DE10004572A1 (de) | 2000-02-02 | 2000-02-02 | Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1265904E true PT1265904E (pt) | 2004-11-30 |
Family
ID=7629599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01911553T PT1265904E (pt) | 2000-02-02 | 2001-01-30 | Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US6525045B2 (pt) |
| EP (1) | EP1265904B1 (pt) |
| JP (1) | JP4891510B2 (pt) |
| AR (1) | AR027352A1 (pt) |
| AT (1) | ATE277054T1 (pt) |
| AU (1) | AU2001240561A1 (pt) |
| CA (1) | CA2399377C (pt) |
| CO (1) | CO5261505A1 (pt) |
| DE (2) | DE10004572A1 (pt) |
| DK (1) | DK1265904T3 (pt) |
| ES (1) | ES2228817T3 (pt) |
| MX (1) | MXPA02007460A (pt) |
| PT (1) | PT1265904E (pt) |
| TR (1) | TR200402650T4 (pt) |
| UY (1) | UY26566A1 (pt) |
| WO (1) | WO2001057045A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10004572A1 (de) * | 2000-02-02 | 2001-08-09 | Boehringer Ingelheim Pharma | Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| AU2001243441B2 (en) * | 2000-03-21 | 2004-11-25 | Smithkline Beecham Corporation | Protease inhibitors |
| EP2311440A1 (en) * | 2001-04-05 | 2011-04-20 | Collagenex Pharmaceuticals, Inc. | Controlled delivery of tetracycline compounds and tetracycline derivatives |
| US20030100552A1 (en) | 2001-05-17 | 2003-05-29 | Boehringer Ingelheim Pharma Kg | Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions |
| DE10123952A1 (de) * | 2001-05-17 | 2002-11-21 | Boehringer Ingelheim Pharma | Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| CN1275951C (zh) * | 2001-10-10 | 2006-09-20 | 神经研究公司 | 新的苯并噻嗪衍生物、其制备和应用 |
| US7815391B2 (en) * | 2004-07-23 | 2010-10-19 | Kauppila Richard W | Structural member joints |
| US20060063707A1 (en) * | 2004-09-17 | 2006-03-23 | Lifelike Biomatic, Inc. | Compositions for enhancing memory and methods therefor |
| EP2420489B1 (en) * | 2008-05-05 | 2014-04-23 | Lonza Ltd | Indolesulfonyl protecting groups for protection of guanidino and amino groups |
| WO2010054336A2 (en) * | 2008-11-10 | 2010-05-14 | The Regents Of The University Of California | Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
| EP3008167A4 (en) | 2013-06-13 | 2017-06-07 | VeroScience LLC | Compositions and methods for treating metabolic disorders |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8724566D0 (en) * | 1987-10-20 | 1987-11-25 | Roussel Lab Ltd | Chemical compounds |
| US4994452A (en) * | 1989-11-28 | 1991-02-19 | Hoechst-Roussel Pharmaceuticals Inc. | Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds |
| CA2130096A1 (fr) * | 1992-04-15 | 1993-10-28 | Jean-Claude Aloup | Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant |
| DE69518075T2 (de) * | 1994-05-24 | 2001-03-22 | F. Hoffmann-La Roche Ag, Basel | Tricyclische dicarbonylderivate |
| US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| WO1998012185A1 (en) * | 1996-09-17 | 1998-03-26 | The Regents Of The University Of California | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
| US5968928A (en) * | 1996-09-19 | 1999-10-19 | Warner-Lambert Company | Excitatory amino acid antagonists: fused-azacyclic quinoxalinediones and immunoassays thereof |
| US5969138A (en) * | 1996-11-01 | 1999-10-19 | Mitsui Chemicals, Inc. | Pyrrolidinone derivatives |
| US5985871A (en) * | 1997-12-24 | 1999-11-16 | Cortex Pharmaceuticals, Inc. | Benzoxazine compounds for enhancing synaptic response |
| NZ506251A (en) * | 1998-02-18 | 2003-01-31 | Neurosearch As | Benzothiadiazine and benzothiadiazepine derivatives and their use as positive AMPA receptor modulators |
| US6096744A (en) * | 1998-05-04 | 2000-08-01 | Warner-Lambert Company | Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| DE10004572A1 (de) * | 2000-02-02 | 2001-08-09 | Boehringer Ingelheim Pharma | Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
-
2000
- 2000-02-02 DE DE10004572A patent/DE10004572A1/de not_active Withdrawn
-
2001
- 2001-01-30 JP JP2001557876A patent/JP4891510B2/ja not_active Expired - Fee Related
- 2001-01-30 EP EP01911553A patent/EP1265904B1/de not_active Expired - Lifetime
- 2001-01-30 TR TR2004/02650T patent/TR200402650T4/xx unknown
- 2001-01-30 AU AU2001240561A patent/AU2001240561A1/en not_active Abandoned
- 2001-01-30 CA CA002399377A patent/CA2399377C/en not_active Expired - Fee Related
- 2001-01-30 AT AT01911553T patent/ATE277054T1/de active
- 2001-01-30 WO PCT/EP2001/000960 patent/WO2001057045A1/de active IP Right Grant
- 2001-01-30 PT PT01911553T patent/PT1265904E/pt unknown
- 2001-01-30 DE DE50103760T patent/DE50103760D1/de not_active Expired - Lifetime
- 2001-01-30 ES ES01911553T patent/ES2228817T3/es not_active Expired - Lifetime
- 2001-01-30 UY UY26566A patent/UY26566A1/es not_active Application Discontinuation
- 2001-01-30 MX MXPA02007460A patent/MXPA02007460A/es active IP Right Grant
- 2001-01-30 DK DK01911553T patent/DK1265904T3/da active
- 2001-01-31 CO CO01007094A patent/CO5261505A1/es not_active Application Discontinuation
- 2001-01-31 US US09/774,864 patent/US6525045B2/en not_active Expired - Lifetime
- 2001-02-02 AR ARP010100494A patent/AR027352A1/es not_active Suspension/Interruption
-
2003
- 2003-01-06 US US10/336,876 patent/US20030158181A1/en not_active Abandoned
- 2003-01-06 US US10/336,865 patent/US6800623B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK1265904T3 (da) | 2004-10-25 |
| CO5261505A1 (es) | 2003-03-31 |
| UY26566A1 (es) | 2001-08-27 |
| CA2399377A1 (en) | 2001-08-09 |
| US20030158183A1 (en) | 2003-08-21 |
| MXPA02007460A (es) | 2003-01-28 |
| DE50103760D1 (de) | 2004-10-28 |
| AU2001240561A1 (en) | 2001-08-14 |
| CA2399377C (en) | 2008-12-16 |
| US6800623B2 (en) | 2004-10-05 |
| JP2003522180A (ja) | 2003-07-22 |
| ES2228817T3 (es) | 2005-04-16 |
| US6525045B2 (en) | 2003-02-25 |
| AR027352A1 (es) | 2003-03-26 |
| EP1265904A1 (de) | 2002-12-18 |
| EP1265904B1 (de) | 2004-09-22 |
| TR200402650T4 (tr) | 2004-11-22 |
| JP4891510B2 (ja) | 2012-03-07 |
| US20020013313A1 (en) | 2002-01-31 |
| US20030158181A1 (en) | 2003-08-21 |
| ATE277054T1 (de) | 2004-10-15 |
| WO2001057045A1 (de) | 2001-08-09 |
| DE10004572A1 (de) | 2001-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1263729T3 (da) | Cykliske azaforbindelser til anvendelse til behandling af serotoninrealterede sygdomme | |
| AU5584901A (en) | Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease | |
| BR0210855A (pt) | Método de fabricação de formulações de liberação prolongada | |
| HK1026691A1 (en) | Substituted benzimidazoles and their use for treating retroviral infection | |
| SE0100568D0 (sv) | Compounds | |
| ATE342728T1 (de) | Zubereitung zur behandlung von einer neurologischen erkrankung | |
| DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| SE0104248D0 (sv) | Method of treatment | |
| CY1111396T1 (el) | Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης | |
| PT1265904E (pt) | Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento | |
| IL162384A0 (en) | Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases | |
| GB0130677D0 (en) | Medicaments and novel compounds | |
| SE0100566D0 (sv) | Compounds | |
| ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
| EP1453507A4 (en) | SOLUBILIZED TOPOISOMERASE GIFT MEDIUM | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| SE0101692D0 (sv) | Compounds | |
| NO20003481L (no) | FremgangsmÕte for behandling av COPD | |
| DE60230652D1 (de) | Arylsulfanyl und heteroarylsulfanyl-derivate zur behandlung von schmerz | |
| MXPA03010737A (es) | Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion. | |
| PT1276722E (pt) | Inibidores de naftamidina-uroquinase | |
| HUP9904578A2 (hu) | Xanomelin alkalmazása bipoláris depresszió kezelésére szolgáló gyógyszerkészítmények előállítására | |
| DE60022047D1 (de) | Antivirale therapie |